Literature DB >> 26455655

Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.

Yan Dong1, Kehuang Li1, Zhixiang Xu1, Haikuo Ma1, Jiyue Zheng2, Zhilin Hu3, Sudan He3, Yiyuan Wu4, Zhijian Sun4, Lusong Luo5, Jiajun Li1, Hongjian Zhang1, Xiaohu Zhang6.   

Abstract

The Wnt signaling pathway is a pivotal developmental pathway. It operates through control of cellular functions such as proliferation, differentiation, migration and polarity. Aberrant Wnt signaling has been implicated in the formation and metastasis of tumors. Porcupine is a component of the Wnt signaling pathway. It is a member of the membrane-bound O-acyltransferase family of proteins. Porcupine catalyzes the palmitoylation of Wnt proteins, a process which is essential to their secretion and activity. Here we report a novel series of compounds obtained by a scaffold hybridization strategy from two known porcupine inhibitor classes. The leading compound 62 demonstrated subnanomolar (IC50 0.11 nM) inhibition of Wnt signaling in a paracrine cellular reporter gene assay. Compound 62 also potently inhibited Wnt secretion into culture medium, an indication of direct inhibition of the porcupine protein. Furthermore, compound 62 showed excellent chemical, plasma and liver microsomal stabilities. Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antagonist; Cancer therapy; Porcupine; Scaffold hybridization; Wnt signaling pathway

Mesh:

Substances:

Year:  2015        PMID: 26455655     DOI: 10.1016/j.bmc.2015.09.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors.

Authors:  Dai Cheng; Jun Liu; Dong Han; Guobao Zhang; Wenqi Gao; Mindy H Hsieh; Nicholas Ng; Shailaja Kasibhatla; Celin Tompkins; Jie Li; Auzon Steffy; Fangxian Sun; Chun Li; H Martin Seidel; Jennifer L Harris; Shifeng Pan
Journal:  ACS Med Chem Lett       Date:  2016-05-10       Impact factor: 4.345

2.  Development of a triazole class of highly potent Porcn inhibitors.

Authors:  Lin You; Chengwei Zhang; Nageswari Yarravarapu; Lorraine Morlock; Xiaolei Wang; Lishu Zhang; Noelle S Williams; Lawrence Lum; Chuo Chen
Journal:  Bioorg Med Chem Lett       Date:  2016-11-11       Impact factor: 2.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.